Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Erica Wood and Lise Estcourt.
Erica Wood
Connection Strength
0.634
Lise Estcourt
  1. How should we use convalescent plasma therapies for the management of COVID-19? Blood. 2021 03 25; 137(12):1573-1581.
    View in: PubMed
    Score: 0.234
  2. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 09 02; 9:CD013825.
    View in: PubMed
    Score: 0.060
  3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 05 20; 5:CD013600.
    View in: PubMed
    Score: 0.059
  4. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 10 12; 10:CD013600.
    View in: PubMed
    Score: 0.057
  5. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
    View in: PubMed
    Score: 0.057
  6. Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities. Vox Sang. 2021 Jan; 116(1):88-98.
    View in: PubMed
    Score: 0.056
  7. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 07 10; 7:CD013600.
    View in: PubMed
    Score: 0.056
  8. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Cochrane Database Syst Rev. 2020 05 14; 5:CD013600.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.